Trial Profile
Safety and pharmacokinetics of LJP538, LJP539, and their combination (CSJ148) in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Apr 2016
Price :
$35
*
At a glance
- Drugs CSJ 148 (Primary)
- Indications Cytomegalovirus infections
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 26 Apr 2016 New trial record.
- 29 Feb 2016 Results published in the Antimicrobial Agents and Chemotherapy